Healthcare Sales & Marketing Network News: Biovail

Searching News Database: Biovail

HSMN NewsFeed - 6 Sep 2013
Osmotica Pharmaceutical Corp. Announces the Appointment of Gene Wright, Pharm.D., Ph.D. as Vice President, Head of Global Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jun 2013
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 4 Sep 2012
Two New Executives Join VaxInnate Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2012
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Mar 2012
Alkermes Appoints Mark Stejbach as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Feb 2012
Santarus Announces FDA Acceptance of UCERIS New Drug Application for Induction of Remission of Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 13 Feb 2012
Santarus Announces Initiation of Phase IIIb Study with UCERIS in Patients with Mild or Moderate Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 6 Feb 2012
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
Biopharmaceuticals

HSMN NewsFeed - 30 Jan 2012
ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Sep 2011
Cornerstone Therapeutics Appoints New President
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2011
Santarus and Pharming Announce Receipt of FDA Refusal to File Letter for RHUCIN Biologics License Application
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2011
Santarus and Pharming Announce Initiation of Phase IIIb Clinical Study with RHUCIN in Acute Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 3 Feb 2011
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 28 Dec 2010
Pharming and Santarus announce submission of Rhucin Biologics License Application to FDA
Biopharmaceuticals

HSMN NewsFeed - 17 Nov 2010
Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2010
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 4 Nov 2010
Valeant Pharmaceuticals and Gradient Analytics Settle Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 28 Oct 2010
ACADIA Pharmaceuticals Enters Agreement with Biovail to Conclude Collaboration and Regain North American Rights to Pimavanserin
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2010
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2010
Valeant and Biovail Complete Merger
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Sep 2010
Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 12 Aug 2010
Darl Moreland Joins Alexza Pharmaceuticals as Vice President, Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2010
Valeant and Biovail Agree to Merge
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 May 2010
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder
Biopharmaceuticals

HSMN NewsFeed - 26 Mar 2010
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 25 Mar 2010
Santarus Announces Completion of Enrollment in U.S. Phase III Clinical Study for Budesonide MMX
Biopharmaceuticals Drug Delivery Gastroenterology

HSMN NewsFeed - 22 Jan 2010
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial
Biopharmaceuticals Generics

HSMN NewsFeed - 1 Sep 2009
ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Aug 2009
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 May 2009
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 11 May 2009
Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2009
GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
Biopharmaceuticals Asquisitions

HSMN NewsFeed - 6 May 2009
Biovail Announces Acquisition of U.S. Rights to Wellbutrin XL
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 4 May 2009
Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin
Biopharmaceuticals Licensing Neurology

HSMN NewsFeed - 7 Apr 2009
TransMolecular Appoints Robert Radie President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Apr 2009
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
Biopharmaceuticals

HSMN NewsFeed - 22 Dec 2008
Biovail Enters into Commercial Alliance for Aplenzin
Biopharmaceuticals Distribution

HSMN NewsFeed - 15 Dec 2008
COSMO ANNOUNCES STRATEGIC COLLABORATION WITH SANTARUS FOR U.S. RIGHTS TO BUDESONIDE MMX® AND RIFAMYCIN SV MMX®
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 11 Dec 2008
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Dec 2008
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Oct 2008
Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2008
MiddleBrook Pharmaceuticals Announces Changes to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2008
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Aug 2008
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 9 Jun 2008
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
Biopharmaceuticals Ophthalmology Drug Delivery Personnel

HSMN NewsFeed - 30 May 2008
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 1 May 2008
XenoPort Appoints Vincent J. Angotti as Chief Commercialization Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Apr 2008
Biovail Strengthens Leadership Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 2 Apr 2008
Bradmer announces new additions to management team
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Mar 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2008
Depomed Names Abid Rawn Vice President of Sales and Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Feb 2008
Biovail Receives Letter Related to 2003 Cardizem(R) LA Launch Activities from U.S. Attorney's Office
Biopharmaceuticals

HSMN NewsFeed - 2 Jan 2008
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Biopharmaceuticals Distribution

HSMN NewsFeed - 2 Jan 2008
Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals FDA Endocrinology Drug Delivery

HSMN NewsFeed - 4 Dec 2007
Watson and Biovail Settle Lawsuit Over Cardizem(R) LA
Biopharmaceuticals Litigation

HSMN NewsFeed - 4 Dec 2007
Biovail Announces Settlement Agreement Related to Cardizem(R) LA
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 3 Dec 2007
Depomed Names Michael Sweeney Vice President of Product Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Nov 2007
Biovail Enters into Development Agreement
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
Biovail Launches Ralivia(TM) to Canadian Physicians
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 29 Oct 2007
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 11 Oct 2007
Depomed Announces Retirement of Chief Financial Officer John F. Hamilton
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
Depomed Announces Reduction in Force
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2007
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2007
Biovail Responds to Investor Enquiries
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 20 Jul 2007
Biovail Provides Update on BVF-033
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 10 Jul 2007
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 5 Jul 2007
Depomed Reacquires the Rights to ProQuin(R) XR
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 26 Jun 2007
Auriga Laboratories Appoints Leonhard Dreimann and Thomas Heck to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 May 2007
Biovail Chairman Eugene Melnyk Announces Retirement
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Apr 2007
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2007
SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 5 Mar 2007
IMPAX Settles Patent Litigation Related to Generic Wellbutrin(R) XL
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Mar 2007
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Mar 2007
Biovail Announces Comprehensive Settlement Related to Wellbutrin XL(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 12 Feb 2007
Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 16 Jan 2007
Wellbutrin XR(R) Receives First European Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Dec 2006
Sciele Pharma Signs Exclusive Zovirax(R) Promotional Agreement with Biovail
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2006
Biovail Enters into Exclusive Promotional Agreement for Zovirax(R)
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2006
IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Dec 2006
Anchen Announces Approval of Generic Version of Wellbutrin XL(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Dec 2006
Biovail Provides Strategy Update
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 6 Dec 2006
Endo Pharmaceuticals Appoints Charles Rowland as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2006
Biovail Announces Senior Management Change
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2006
Biovail and Athpharma Terminate Joint Development Agreement
Biopharmaceuticals

HSMN NewsFeed - 19 Jul 2006
TriPath Imaging, Inc. Announces Promotions of Johnny D. Powers, Ph.D. to President, TriPath Oncology and James D. Petrilla to Senior Vice President, Commercial Operations
Diagnostics Oncology Personnel

HSMN NewsFeed - 28 Jun 2006
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 May 2006
Biovail to Promote Novartis' Lescol(R) Franchise in Canada; Lescol(R) Provides Treatment Option for Patients Who Need a Statin to Reduce Cardiovascular Risk
Biopharmaceuticals

HSMN NewsFeed - 11 May 2006
Esprit Pharma Appoints Vice President of Trade
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 90

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 90 additional stories matching:
Biovail
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.